Controversy Surrounds Change in Newborn Hepatitis B Vaccine Policy

A group of advisors to U.S. Health Secretary Robert F. Kennedy Jr. voted to remove the universal hepatitis B vaccine recommendation for newborns. Experts express concern about increased risk of disease. The decision is seen as regressive and likely to create confusion among health professionals.

A significant shift in vaccine policy occurred as a group of advisors to U.S. Health Secretary Robert F. Kennedy Jr. voted to eliminate the universal recommendation for newborns to receive the hepatitis B vaccine. This decision marks a dramatic change in public health policy.

Medical experts, including Noel Brewer, a former member of the Advisory Committee on Immunization Practices (ACIP), strongly criticize the move, asserting that it limits parental choices and elevates health risks for children. Dr. Cody Meissner argues this change contravenes the 'do no harm' ethical principle.

Dr. William Schaffner of Vanderbilt University warns this vote sets back progress to pre-1991 standards, potentially leading to widespread confusion among healthcare providers. Major medical organizations are expected to continue recommending the vaccine at birth despite this controversial vote.

(With inputs from agencies.)